• Pomdoctor schedules an extraordinary general meeting of shareholders in Guangzhou on Sept. 30, 2026.
• Vote on ending the ADR program, shifting from Nasdaq-traded ADSs to a direct listing of Class A ordinary shares.
• Consider a 10-for-1 share consolidation, affecting Class A and Class B ordinary shares, to take effect with the listing change.
• Resolution also seeks authority to adjourn the meeting if more time is needed to secure votes on the main items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-097663), on September 04, 2026, and is solely responsible for the information contained therein.